Cargando…
Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314659/ https://www.ncbi.nlm.nih.gov/pubmed/32588188 http://dx.doi.org/10.1007/s11481-020-09938-3 |
| _version_ | 1783550103919788032 |
|---|---|
| author | Cure, Erkan Cumhur Cure, Medine Kucuk, Adem |
| author_facet | Cure, Erkan Cumhur Cure, Medine Kucuk, Adem |
| author_sort | Cure, Erkan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7314659 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73146592020-06-25 Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” Cure, Erkan Cumhur Cure, Medine Kucuk, Adem J Neuroimmune Pharmacol Letter to the Editor Springer US 2020-06-25 2020 /pmc/articles/PMC7314659/ /pubmed/32588188 http://dx.doi.org/10.1007/s11481-020-09938-3 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Cure, Erkan Cumhur Cure, Medine Kucuk, Adem Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title | Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title_full | Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title_fullStr | Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title_full_unstemmed | Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title_short | Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
| title_sort | comment on “smooth or risky revisit of an old malaria drug for covid-19?” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314659/ https://www.ncbi.nlm.nih.gov/pubmed/32588188 http://dx.doi.org/10.1007/s11481-020-09938-3 |
| work_keys_str_mv | AT cureerkan commentonsmoothorriskyrevisitofanoldmalariadrugforcovid19 AT cumhurcuremedine commentonsmoothorriskyrevisitofanoldmalariadrugforcovid19 AT kucukadem commentonsmoothorriskyrevisitofanoldmalariadrugforcovid19 |